Curated News
By: NewsRamp Editorial Staff
July 23, 2026
SS Innovations to Showcase SSi Mantra Robotic System at SRS 2026
TLDR
- SS Innovations showcases its SSi Mantra robot at SRS 2026, with over 12,375 procedures completed, signaling market leadership.
- The SSi Mantra system enables telesurgery via live kidney surgery broadcast from India, demonstrating remote surgical capabilities.
- Over 12,375 procedures and 2,100 trained physicians expand access to advanced robotic surgery, improving patient outcomes globally.
- A live partial nephrectomy will be performed remotely from India to Florida, showcasing telesurgery's potential.
Impact - Why it Matters
This news matters because it highlights a significant leap in surgical robotics: the ability to perform telesurgery across continents using the SSi Mantra system. For patients in underserved or remote areas, this technology could mean access to world-class surgical expertise without the need for travel. For the medical community, it demonstrates the growing feasibility of remote procedures, potentially reducing healthcare disparities. Investors should note SS Innovations' expanding clinical footprint and the system's versatility across over 170 procedures, signaling strong market potential.
Summary
SS Innovations International (NASDAQ: SSII), a pioneering developer of surgical robotic technologies, is set to showcase its groundbreaking SSi Mantra surgical robotic system at the Society of Robotic Surgery (“SRS”) 2026 Annual Meeting, taking place from July 23-26 in Hollywood, Florida. The company announced that the SSi Mantra will be a central feature of the conference, with its capabilities demonstrated through multiple technical sessions and a live robotic telesurgery broadcast. During the event, a partial nephrectomy will be performed remotely from India, highlighting the platform's advanced telesurgery capabilities. Chairman and CEO Dr. Sudhir Srivastava will participate in several conference presentations covering key topics such as telesurgery, the adoption of robotic surgery, and regulatory developments. This marks a significant milestone for SS Innovations as it continues to expand its global clinical footprint with the SSi Mantra system.
As of July 6, 2026, the SSi Mantra has been used to complete over 12,375 procedures, including complex cardiac, pediatric, and telesurgical operations. More than 2,100 physicians have already been trained on the platform, which has been utilized across over 170 different surgical procedures. This extensive clinical experience underscores the system's versatility and reliability in various surgical settings. The SRS 2026 Annual Meeting provides a premier platform for SS Innovations to demonstrate the SSi Mantra's capabilities to a global audience of robotic surgery specialists, potentially accelerating its adoption in new markets. The live telesurgery broadcast is particularly noteworthy as it showcases the system's potential to bridge geographic gaps in surgical expertise, enabling specialists to perform procedures remotely.
For investors and industry observers, the latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII. The company’s participation in SRS 2026 underscores its commitment to advancing surgical robotics and expanding access to minimally invasive procedures worldwide. With a growing body of clinical evidence and a robust training program for physicians, SS Innovations is positioning itself as a key player in the global surgical robotics market. The conference will also feature the SSi Mantra in the TechMediaWire coverage, ensuring broad visibility among technology and healthcare audiences.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations to Showcase SSi Mantra Robotic System at SRS 2026
